BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17620488)

  • 1. Metabolic alterations in patients with Parkinson disease and visual hallucinations.
    Boecker H; Ceballos-Baumann AO; Volk D; Conrad B; Forstl H; Haussermann P
    Arch Neurol; 2007 Jul; 64(7):984-8. PubMed ID: 17620488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations.
    Oishi N; Udaka F; Kameyama M; Sawamoto N; Hashikawa K; Fukuyama H
    Neurology; 2005 Dec; 65(11):1708-15. PubMed ID: 16344511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 2A receptors and visual hallucinations in Parkinson disease.
    Ballanger B; Strafella AP; van Eimeren T; Zurowski M; Rusjan PM; Houle S; Fox SH
    Arch Neurol; 2010 Apr; 67(4):416-21. PubMed ID: 20385906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
    Gasca-Salas C; Clavero P; García-García D; Obeso JA; Rodríguez-Oroz MC
    Hum Brain Mapp; 2016 Mar; 37(3):968-77. PubMed ID: 26663702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Functional Connectivity in Patients with Parkinson Disease and Visual Hallucinations.
    Hepp DH; Foncke EMJ; Olde Dubbelink KTE; van de Berg WDJ; Berendse HW; Schoonheim MM
    Radiology; 2017 Dec; 285(3):896-903. PubMed ID: 28952907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual hallucination in Parkinson's disease with FDG PET.
    Nagano-Saito A; Washimi Y; Arahata Y; Iwai K; Kawatsu S; Ito K; Nakamura A; Abe Y; Yamada T; Kato T; Kachi T
    Mov Disord; 2004 Jul; 19(7):801-806. PubMed ID: 15254938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pareidolia in Parkinson's disease without dementia: A positron emission tomography study.
    Uchiyama M; Nishio Y; Yokoi K; Hosokai Y; Takeda A; Mori E
    Parkinsonism Relat Disord; 2015 Jun; 21(6):603-9. PubMed ID: 25864093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual hallucinations and cognitive impairment in Parkinson's disease.
    Park HK; Kim JS; Im KC; Kim MJ; Lee JH; Lee MC; Kim J; Chung SJ
    Can J Neurol Sci; 2013 Sep; 40(5):657-62. PubMed ID: 23968938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations.
    Perneczky R; Drzezga A; Boecker H; Förstl H; Kurz A; Häussermann P
    Dement Geriatr Cogn Disord; 2008; 25(6):531-8. PubMed ID: 18477846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
    Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W
    Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of Metabolic Connectivity in Dementia with Lewy Bodies with Visual Hallucinations: A
    Zorzi G; Cecchin D; Bussè C; Perini G; Corbetta M; Cagnin A
    Brain Connect; 2021 Sep; 11(7):518-528. PubMed ID: 33757301
    [No Abstract]   [Full Text] [Related]  

  • 12. Resting activity in visual and corticostriatal pathways in Parkinson's disease with hallucinations.
    Yao N; Pang S; Cheung C; Chang RS; Lau KK; Suckling J; Yu K; Mak HK; McAlonan G; Ho SL; Chua SE
    Parkinsonism Relat Disord; 2015 Feb; 21(2):131-7. PubMed ID: 25511330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brain metabolic signature of visual hallucinations in dementia with Lewy bodies.
    Iaccarino L; Sala A; Caminiti SP; Santangelo R; Iannaccone S; Magnani G; Perani D
    Cortex; 2018 Nov; 108():13-24. PubMed ID: 30098477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral atrophy in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Martí MJ; Tolosa E; Giménez M; Bargalló N; Valldeoriola F; Junqué C
    Eur J Neurol; 2007 Jul; 14(7):750-6. PubMed ID: 17594330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson's disease patients with visual hallucinations.
    Hepp DH; Foncke EMJ; Berendse HW; Wassenaar TM; Olde Dubbelink KTE; Groenewegen HJ; D J van de Berg W; Schoonheim MM
    Sci Rep; 2017 Aug; 7(1):10112. PubMed ID: 28860465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.
    Lenka A; Jhunjhunwala KR; Saini J; Pal PK
    Parkinsonism Relat Disord; 2015 Jul; 21(7):683-91. PubMed ID: 25920541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant functional connectivity of resting state networks related to misperceptions and intra-individual variability in Parkinson's disease.
    Miloserdov K; Schmidt-Samoa C; Williams K; Weinrich CA; Kagan I; Bürk K; Trenkwalder C; Bähr M; Wilke M
    Neuroimage Clin; 2020; 25():102076. PubMed ID: 31794926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies.
    Ibarretxe-Bilbao N; Junque C; Marti MJ; Tolosa E
    J Neurol Sci; 2011 Nov; 310(1-2):79-81. PubMed ID: 21705027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.
    Hepp DH; da Hora CC; Koene T; Uitdehaag BM; van den Heuvel OA; Klein M; van de Berg WD; Berendse HW; Foncke EM
    Parkinsonism Relat Disord; 2013 Sep; 19(9):795-9. PubMed ID: 23706540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB).
    Imamura T; Ishii K; Hirono N; Hashimoto M; Tanimukai S; Kazuai H; Hanihara T; Sasaki M; Mori E
    Neuroreport; 1999 Jun; 10(9):1903-7. PubMed ID: 10501530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.